Abstract
The atypical antipsychotic asenapine extended the time to recurrence of any mood episode when compared with placebo in a 26‐week maintenance trial for patients with bipolar disorder, researchers have reported. The results are significant in that many treatments used for bipolar disorder appear to be more effective in controlling manic or depressive symptoms but not both. Study results were published online Sept. 26 in the American Journal of Psychiatry.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
